Not yet a member?Join now!|Lost password
AMT - Amsterdam Molecular Therapeutics Holding NV
AMT - Amsterdam Molecular Therapeutics Holding NV
11/06/2012 | Press release
Amsterdam Molecular Therapeutics (in liquidation) announces delisting and expected finalisation of liquidation process
distributed by noodls on 11/06/2012 09:12
Amsterdam Molecular Therapeutics (in
liquidation) announces delisting and expected finalisation
of liquidation processAmsterdam Molecular Therapeutics (in
liquidation) announces delisting and expected finalisation
of liquidation process
Nov 6, 2012
Amsterdam Molecular Therapeutics (in liquidation) announces
delisting and expected finalisation of liquidation process
Amsterdam, The Netherlands - November 6, 2012 - Amsterdam Molecular Therapeutics (AMT) Holding NV in liquidation (in liquidatie) (Euronext: AMT) announces that NYSE Euronext has determined and announced that as of 19 November 2012, AMT's shares will be delisted from NYSE Euronext in Amsterdam, the Netherlands with 16 November 2012 being the last trading date.
On 12 September 2012, the account and justification (rekening en verantwoording) as prepared by AMT's liquidators was made available for inspection at the Chamber of Commerce of Amsterdam (De Ruyterkade 5, Amsterdam) and at AMT's offices (Meibergdreef 61, Amsterdam Zuidoost), and on 14 September 2012 notice of the same was given in a national newspaper. Absent any surplus following the final settlement of the remaining assets and liabilities, no plan of distribution (plan van verdeling) was prepared.
Assuming that no action (verzet) will be instituted against the account and justification, AMT's liquidators expect to finalise the liquidation on or shortly following 19 November 2012. There will not be any (final) distributions to AMT shareholders in the context of the finalisation of the liquidation or otherwise. When the liquidation ends, AMT and its shares shall cease to exist.
Further information on AMT (in liquidation), can be found on AMT (in liquidation)'s website www.amtbiopharma.com.
For further enquiries:
Jörn Aldag
Liquidator
AMT (in liquidation)
Tel : +31 20 566 8014
j.aldag@amtbiopharma.com
Close
